The Patent Finder

Faron Pharmaceuticals Oy

Also on record
Records under this name other than the patents Faron Pharmaceuticals Oy holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.

Showing 1 to 4 of 4 · Back to Faron Pharmaceuticals Oy

PatentTitleStatus Expires Confidence
US 7,534,423Method for inducing an elevated level of adenosine in an individual
Term ended
Term ended Nov 30, 2024 · From the USPTO record
Term endedTerm ended Nov 30, 2024From the USPTO record
US 7,910,097Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof
Term ended
Term ended Mar 25, 2023 · From the USPTO record
Term endedTerm ended Mar 25, 2023From the USPTO record
US 7,354,577Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof
Term ended
Term ended Mar 22, 2023 · From the USPTO record
Term endedTerm ended Mar 22, 2023From the USPTO record
US 8,119,651Compositions useful especially for treatment or prevention of metabolic syndrome
Formerly held
Lapsed on the fee record
Ended Feb 21, 2016 · From the USPTO record
Lapsed on the fee recordEnded Feb 21, 2016From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited